Business Description
Kyorin Pharmaceutical Co Ltd
NAICS : 325411
SIC : 2833
ISIN : JP3247090008
Description
Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.67 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | 2.96 | |||||
Interest Coverage | 91.12 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.62 | |||||
Beneish M-Score | -2.38 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.1 | |||||
3-Year EBITDA Growth Rate | -1.8 | |||||
3-Year EPS without NRI Growth Rate | 1.3 | |||||
3-Year Book Growth Rate | 1.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.62 | |||||
Quick Ratio | 1.45 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 273.32 | |||||
Days Sales Outstanding | 134.5 | |||||
Days Payable | 72.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.59 | |||||
3-Year Dividend Growth Rate | -11.5 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 3.33 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 43.01 | |||||
Operating Margin % | 5.03 | |||||
Net Margin % | 4.45 | |||||
FCF Margin % | -3.82 | |||||
ROE % | 4.2 | |||||
ROA % | 3.02 | |||||
ROIC % | 3.21 | |||||
ROC (Joel Greenblatt) % | 6.98 | |||||
ROCE % | 5.16 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.15 | |||||
PE Ratio without NRI | 19.52 | |||||
Shiller PE Ratio | 14.29 | |||||
PS Ratio | 0.81 | |||||
PB Ratio | 0.74 | |||||
Price-to-Tangible-Book | 0.77 | |||||
Price-to-Operating-Cash-Flow | 62.35 | |||||
EV-to-EBIT | 14.63 | |||||
EV-to-EBITDA | 14.63 | |||||
EV-to-Revenue | 0.87 | |||||
EV-to-FCF | -22.07 | |||||
Price-to-Projected-FCF | 0.94 | |||||
Price-to-Median-PS-Value | 0.67 | |||||
Price-to-Graham-Number | 0.82 | |||||
Price-to-Net-Current-Asset-Value | 1.34 | |||||
Earnings Yield (Greenblatt) % | 6.84 | |||||
FCF Yield % | -4.86 | |||||
Forward Rate of Return (Yacktman) % | -1.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KYRNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kyorin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 820.134 | ||
EPS (TTM) ($) | 0.636 | ||
Beta | -0.01 | ||
Volatility % | 1.29 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 18.55 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 18.55 - 18.55 | ||
Shares Outstanding (Mil) | 57.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kyorin Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kyorin Pharmaceutical Co Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Kyorin Pharmaceutical Co Ltd Frequently Asked Questions
What is Kyorin Pharmaceutical Co Ltd(KYRNF)'s stock price today?
The current price of KYRNF is $18.55. The 52 week high of KYRNF is $18.55 and 52 week low is $18.55.
When is next earnings date of Kyorin Pharmaceutical Co Ltd(KYRNF)?
The next earnings date of Kyorin Pharmaceutical Co Ltd(KYRNF) is .
Does Kyorin Pharmaceutical Co Ltd(KYRNF) pay dividends? If so, how much?
Kyorin Pharmaceutical Co Ltd(KYRNF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |